Package 51662-1564-3

Brand: ziprasidone mesylate

Generic: ziprasidone mesylate
NDC Package

Package Facts

Identity

Package NDC 51662-1564-3
Digits Only 5166215643
Product NDC 51662-1564
Product ID 51662-1564_1035b793-4301-3cb4-e063-6294a90a5b1f
Description

10 POUCH in 1 CASE (51662-1564-3) / 1 VIAL, SINGLE-DOSE in 1 POUCH (51662-1564-2) / 5 mL in 1 VIAL, SINGLE-DOSE

Marketing

Marketing Status
Marketed Since 2021-07-17
Brand ziprasidone mesylate
Generic ziprasidone mesylate
Sample Package No

Linked Drug Pages (1)

ZIPRASIDONE MESYLATE ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAMUSCULAR"], "spl_id": "1035b793-4301-3cb4-e063-6294a90a5b1f", "openfda": {"unii": ["3X6SAX83JZ"], "rxcui": ["351223"], "spl_set_id": ["c75971f8-9640-a6e8-e053-2995a90af654"], "manufacturer_name": ["HF Acquisition Co LLC, DBA HealthFirst"]}, "finished": true, "packaging": [{"sample": false, "description": "10 POUCH in 1 CASE (51662-1564-3)  / 1 VIAL, SINGLE-DOSE in 1 POUCH (51662-1564-2)  / 5 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "51662-1564-3", "marketing_start_date": "20210717"}], "brand_name": "ZIPRASIDONE MESYLATE", "product_id": "51662-1564_1035b793-4301-3cb4-e063-6294a90a5b1f", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Atypical Antipsychotic [EPC]"], "product_ndc": "51662-1564", "generic_name": "ZIPRASIDONE MESYLATE", "labeler_name": "HF Acquisition Co LLC, DBA HealthFirst", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ZIPRASIDONE MESYLATE", "active_ingredients": [{"name": "ZIPRASIDONE MESYLATE", "strength": "20 mg/mL"}], "application_number": "ANDA211908", "marketing_category": "ANDA", "marketing_start_date": "20210717", "listing_expiration_date": "20261231"}